Stock listing

NASDAQ:AIMT Aimmune Therapeutics Inc Stock

Follow Aimmune Therapeutics Inc into a list and get an email when it puts out news.

Last close · NASDAQ:AIMT

$34.49 USD

Close on Oct 13, 2020 · No longer trades

Aug 5, 2015 to last close +115.6% · weekly closes, Aug 5, 2015 – Oct 13, 2020
Lowest – highest close
$10.26 – $39.55 USDSince Aug 5, 2015 · lowest Jul 7, 2016 · highest Dec 22, 2017

Delisted NASDAQ:AIMT no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:AIMT
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Aimmune Therapeutics Inc on 6ix

Decks
4 decks · latest Jun 18, 2019

Decks

DeckKindSlidesDate
Investor Presentation (June 2019)Investor deck36 slidesJun 18, 2019
Corporate Update (November 2018)Corporate update31 slidesNov 19, 2018
Technical Presentation (February 2018)Technical13 slidesFeb 20, 2018
J.P. Morgan Healthcare Conference January 2017Conference22 slidesJan 9, 2017

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Kathryn Falberg
Other companies: Nuvation Bio Inc. (Board of Directors · Since at least Feb 10, 2021); Arcus Biosciences, Inc. (Board Member · Since at least Mar 14, 2018); The Trade Desk, Inc. (Director · Since at least Sep 20, 2016); UroGen Pharma Ltd. (Director · Jan 1, 2019 – Jun 7, 2021 · Past); Tricida Inc (Director · Jun 27, 2018 – Jun 15, 2022 · Past); Sio Gene Therapies Inc (Director · Apr 7, 2017 – May 15, 2017 · Past); BioMarin Pharmaceutical Inc. (Director · Jul 15, 2016 – Jul 15, 2016 · Past); aTyr Pharma, Inc. (Director · May 6, 2015 – May 24, 2016 · Past); Medivation Inc (Director · Jan 31, 2013 – Sep 28, 2016 · Past); Jazz Pharmaceuticals plc (EVP and CFO · Dec 1, 2009 – Mar 5, 2014 · Past); Novelion Therapeutics Inc (Director · Mar 25, 2009 – May 26, 2011 · Past); Oruka Therapeutics, Inc. (CFO and COO · Feb 23, 2009 – Jun 25, 2009 · Past); Halozyme Therapeutics, Inc. (Director · May 15, 2007 – May 4, 2016 · Past)
Director · Aug 5, 2015 – Oct 10, 2020 · Past
Mark Iwicki
Other companies: Inhibikase Therapeutics, Inc. (Chief Executive Officer - Inhibikase · Since at least Feb 14, 2025); Q32 Bio Inc. (Director · Since at least Mar 25, 2024); Third Harmonic Bio Inc. (Director · Since at least Sep 14, 2022); Akero Therapeutics Inc (Director · Since at least Jun 19, 2019); Kala Bio, Inc. (Director · Since at least Jul 19, 2017); Jade Biosciences, Inc. (Director · Apr 2, 2021 – Jun 5, 2024 · Past); Pulmatrix, Inc. (Director · Mar 20, 2017 – Jan 28, 2021 · Past)
Director · May 25, 2016 – Oct 10, 2020 · Past
Jayson Donald Alexander Dallas
Other companies: Damora Therapeutics, Inc. (Director · Since at least Nov 19, 2020); Arena Pharmaceuticals Inc (Director · Feb 13, 2017 – Mar 11, 2022 · Past); Ultragenyx Pharmaceutical Inc. (EVP & Chief Commercial Officer · Aug 3, 2015 – Jun 1, 2018 · Past)
President and CEO, Director · Jun 19, 2018 – Oct 10, 2020 · Past
Stephen George Dilly
Other companies: Codexis, Inc. (Director · Since at least Jun 16, 2020); Sierra Oncology Inc (CEO and President, Director · Jun 1, 2020 – Jul 1, 2022 · Past); Sangamo Therapeutics, Inc. (Director · Jun 12, 2013 – May 18, 2020 · Past)
President and CEO, Director · Aug 5, 2015 – Jun 11, 2018 · Past
Gregory Behar
Other companies: Axcella Health Inc (Director · May 8, 2019 – May 20, 2021 · Past); Seres Therapeutics, Inc. (Director · Jun 25, 2015 – Jun 22, 2023 · Past)
Director · Nov 23, 2016 – Oct 13, 2020 · Past
Brett K Haumann
Other companies: Theravance Biopharma, Inc. (Chief Medical Officer · May 14, 2014 – Feb 20, 2021 · Past)
Director · Oct 31, 2018 – Oct 10, 2020 · Past
Stacey Denenberg Seltzer
Other companies: OnKure Therapeutics, Inc. (Director · Apr 8, 2021 – Jun 6, 2023 · Past)
Director · Aug 5, 2015 – Oct 10, 2020 · Past
Daniel C Md AdelmanChief Medical Officer · Jun 16, 2016 – Oct 10, 2020 · Past
Mary M RozenmanSee Remarks · Aug 5, 2015 – Dec 31, 2019 · Past
Robert Myles ElfontChief Medical Officer · Aug 5, 2015 – Feb 26, 2016 · Past

Open People

Log in to ask 6ix AI your own questions about Aimmune Therapeutics Inc.